引用本文: | Sebastian M,Passlick B,Friccius-Quecke H,J?ger M,Lindhofer H,Kanniess F,Wiewrodt R,Thiel E,Buhl R,Schmittel A.Treatment of non-small cell lung cancer patients with the trifunctional monoclonal antibody catumaxomab (anti-EpCAM?×?anti-CD3): a phase I study[J].Cancer Immunology, Immunotherapy,2007,56(10):1637-1644. |